Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Silke Kern

Senior lecturer/ chief physician

Silke Kern
Senior lecturer/ chief physician , Avd-/sektionschef, bitr, inst
silke.kern@neuro.gu.se
+46 31 786 6850
0762-365332

Postal Address: Blå stråket 15, vån 3 su/sahlgrenska, 413 45 Göteborg
Visiting Address: Blå stråket 15, vån 3 su/sahlgrenska , 413 45 Göteborg


Department of Psychiatry and Neurochemistry at Institute of Neuroscience and Physiology (More Information)
Blå stråket 15, vån 3 SU/Sahlgrenska
413 45 Göteborg
031-342 10 00
Visiting Address: Blå stråket 15, vån 3 SU/Sahlgrenska , 413 45 Göteborg

About Silke Kern

Dr. Silke Kern is an Associate Professor, Senior Lecturer and Senior Consultant Neurologist and Psychiatrist at the Institute of Neuroscience and Physiology, Centre for Ageing and Health, Sahlgrenska Academy at the University of Gothenburg. She is leading all clinical research conducted at the Memory Clinic, Sahlgrenska University Hospital.

Research areas

Dr. Kern's main research focus is fluid biomarkers for Alzheimer's disease in clinical settings as well as in epidemiological research. Dr Kern is leading all clinical research at the Memory Clinic, Sahlgrenska University Hospital and is Principal Investigator for the European Prevention of Alzheimer's disease Trial Delivery Center at the Memory Clinic at Sahlgrenska University Hospital. Dr. Silke Kerns research aim is to increase knowledge about dementia and cognitive disorders from early diagnosis to treatment.

Main research areas are:

  • Biomarkers of Alzheimer's disease in cerebrospinal fluid
  • MRI brain imaging as biomarker for different neurodegenerative diseases
  • Riskfactors for development of different neurodegenerative diseases
  • Incidence and time-changes of dementia over the last decades

 

Latest publications

Predicting Fazekas scores from automatic segmentations of white matter signal abnormalities
N. Cedres, D. Ferreira, A. Machado, S. Shams, Simona Sacuiu et al.
Aging-Us, Journal article 2020
Journal article

Comparison of variables associated with cerebrospinal fluid neurofilament, total-tau, and neurogranin.
Michelle M Mielke, Jeremy A Syrjanen, Kaj Blennow, Henrik Zetterberg, Ingmar Skoog et al.
Alzheimer's & dementia : the journal of the Alzheimer's Association, Journal article 2019
Journal article

Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer's disease progression
S. De, D. R. Whiten, F. S. Ruggeri, C. Hughes, M. Rodrigues et al.
Acta Neuropathologica Communications, Journal article 2019
Journal article

Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype
L. Vermunt, S. A. M. Sikkes, A. van den Hout, R. Handels, I. Bos et al.
Alzheimers & Dementia, Journal article 2019
Journal article

Showing 21 - 30 of 48

2018

Poor Sleep Is Associated with CSF-Markers of Alzheimer’s Disease in 70-Year-Olds without Dementia
Johan Skoog, Henrik Zetterberg, Kaj Blennow, Silke Kern, Boo Johansson et al.
2018’s Alzheimer's Association International Conference, Chicago, USA., Poster 2018
Poster

Subjective Sleep Disturbance is associated with preclinical Alzheimer’s Disease in Cerebrospinal Fluid in a Population-Based Study of 70-Year-Olds without dementia
Johan Skoog, Boo Johansson, Henrik Zetterberg, Kaj Blennow, Valgeir Thorvaldsson et al.
The 19th congress of the Section of Epidemiology and Social Psychiatry of the European Psychiatric Association (EPA), Wien, Österrike., Conference contribution 2018
Conference contribution

2017

Multi-infarct dementia of Swedish type is caused by a 3'UTR mutation of COL4A1.
Maija Siitonen, Anne Börjesson-Hanson, Minna Pöyhönen, Ari Ora, Petra Pasanen et al.
Brain : a journal of neurology, Journal article 2017
Journal article

Showing 21 - 30 of 48

Page Manager: Webbredaktör|Last update: 9/1/2015
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?